Normally, these genes stop breast and
ovarian cells from growing and dividing uncontrollably.
The team tried this method with two types of body cells:
ovarian cells from an adult and connective tissue cells from a fetus.
Rodriguez wondered if the same association might exist in humans, so she analyzed
ovarian cells from women undergoing in vitro fertilization at Johns Hopkins» infertility clinic.
Not exact matches
Because the Augment technique uses mitochondria
from the mother's
ovarian stem
cells rather than a donor, there is no three - parent ethical quagmire to wade through.
Zain Rajani's mother had her eggs «rejuvenated» using mitochondria
from her
ovarian stem
cells.
In the paper, published in the now - defunct online journal e-biomed, West, Lanza and their colleagues showed that they could pull a nucleus
from a human egg
cell, replace it with a whole adult
ovarian cell and generate an embryo that divided into six
cells.
The study published in Cancer
Cell shows that exosomes
from tumor
cells of breast cancer (and other tumor types such as
ovarian and endometrial) are different in size and composition than those of healthy
cells.
Beyond lung cancer, TiY is able to target TICs in 28 types of human
cell lines derived
from the central nervous system, melanoma, breast, renal,
ovarian, colon, and prostate cancer.
The key discovery made by the CSHL team is that FER is able to activate a receptor on the surface of
ovarian cells «
from below,» as it were — by interacting with a portion of the receptor that penetrates the
cell membrane and plunges into the cytoplasm.
Analyzing white blood
cells from 934 patients and 1,698 healthy controls, they found BRCA1 methylation among 6.4 % of patients diagnosed with
ovarian cancer, contrasting 4.2 % among controls.
In addition to the afatinib - resistant NSCLC
cells, the researchers tested the neratinib and valproic acid combination on
cell lines derived
from human pancreatic and
ovarian cancers containing K - Ras mutations and N - Ras mutations, respectively.
The researchers then exposed
cells from each of these lines to a panel of 31 different drug treatments — including 23 chemotherapy compounds approved by the FDA for breast and
ovarian cancers, six targeted cancer drugs, and two common drug combinations.
The research team with international collaborators analysed more than 100 patient samples
from ovarian and other cancer types to discover a distinct population of
cells found in some tumours.
A section of a tumor organoid grown
from cells derived
from a patient with high - grade serous
ovarian cancer (left) and a mini-tumor treated with ReACp53, resulting in extensive cancer
cell death.
Dr. Vasmatzis» research on the «Quantification of Somatic Chromosomal Rearrangements in Circulating
Cell - free DNA
From Ovarian Cancers» is published in the July 20 edition of Scientific Reports.
Egg
cells can also be preserved in their hundreds of thousands by collecting
ovarian tissue
from reproductively active females that die in captivity and dunking it in liquid nitrogen.
In lab experiments, the research team used
cell lines derived
from 40 patient tumour samples to identify that CD151 contributes to the survival of
cells of high - grade serous
ovarian cancer origin.
When the researchers tested the circuit in vitro, they found that it was able to detect
ovarian cancer
cells from amongst other noncancerous
ovarian cells and other
cell types.
Analysing certain genes in these
cells enabled them to detect 33 per cent of
ovarian cancers and 81 per cent of endometrial cancers in Pap test specimens collected
from 627 women already diagnosed with these diseases.
In their initial experiments, Hwang and his colleagues used
cells from a single donor to try to create embryonic clones; they transferred nuclei
from ovarian cells back into the donors» own oocytes.
Ongoing Phase 1b / 2 clinical trials combine entinostat with KEYTRUDA ®
from Merck & Co., Inc. for non-small
cell lung cancer, melanoma and colorectal cancer; with TECENTRIQ ®
from Genentech, Inc. for triple negative breast cancer; and with BAVENCIO ®
from Pfizer Inc. and Merck KGaA, Darmstadt, Germany, for
ovarian cancer.
The study team assessed three sets of outcomes: a maturational index (MI) based on epithelial
cells from the children's urogenital tissue; ultrasound measurements of uterine,
ovarian and testicular volume, as well as breast - buds; and hormone concentrations seen in blood tests.
In the proposed project, Dr. Lampi Hermanson will produce NK
cells from stem
cells, inserting a chimeric antigen receptor (CAR) with the capacity to recognize mesothelin
cells, which is expressed in 70 % of
ovarian cancer patients.
The earliest and one of the most striking came
from observations that the presence of infiltrating T
cells (called «tumor - infiltrating lymphocytes,» or TILs) in
ovarian tumors is positively and strongly associated with improved survival of patients with
ovarian cancer [1].
Their theory was first confirmed with
ovarian cancer
cell lines and then the Peter / Lengyel team tested HGMA2 protein levels in tumor samples
from 100 patients with
ovarian cancer.
The book introduces the incessant menstruation hypothesis, which may allow physicians to better understand and explain to patients why many serous
ovarian cancers may actually be originating
from the fimbriated end of the fallopian tube and why endometrioid and clear
cell cancers may arise in association with endometriosis.
Surveillance of the tumor mutanome by T
cells during progression
from primary to recurrent
ovarian cancer.
Her expertise includes isolation of stem
cells from multiple organs as well as
from solid tumours and fluid aspirates associated with breast and
ovarian tumours.
December 17, 2013 Cancer genetics pioneer Janet Rowley, 1925 - 2013 A pioneer in connecting the development of cancer with genetic abnormalities, Janet D. Rowley, MD, the Blum - Riese Distinguished Service Professor of Medicine, Molecular Genetics &
Cell Biology and Human Genetics at the University of Chicago, died
from complications of
ovarian cancer on December, 17, 2013, at her home.
Six
ovarian factors (BDNF, IGF - I, estradiol, GDNF, leptin and FGF2) were further studied based upon the expression of their receptors in oocytes and cumulus
cells described above, as well as the availability of growth factor concentration information
from previous animal model studies [1], [20], [21], [22], [23].
Review of «Induced Pluripotent Stem
Cell - Derived Natural Killer
Cells for Treatment of
Ovarian Cancer»
from Stem
Cells by Stuart P. Atkinson
He is the principal investigator of an NCI - funded, multi-million-dollar Specialized Program of Research Excellence (SPORE) in
ovarian cancer, and he is the principal investigator of a multi-million-dollar grant
from the New York State Stem
Cell Science program (NYSTEM) to pioneer a novel strategy of reprogramming human mature T
cells and hematopoietic stem
cells for generating sustained attack against
ovarian cancer in patients.
Mock - infected control (A); Severe hemorrhage and regression of
ovarian follicles (B); Spleens
from mock - infected control (left) and enlarged spleens
from the infected ducks (C); HE - stained ovary section showing hemorrhage and follicle rupture with red stained bodies (D); HE - stained brain section revealing lymphocytes and mononuclear
cell infiltration under cranial arachnoid (E) and focal gliosis (arrow)(F).
Olaparib is a PARP inhibitor, which is already used to treat certain
ovarian cancer patients and prevents damaged cancer
cells from repairing themselves after chemotherapy or radiotherapy.
To prepare
ovarian cells,
ovarian tissues were isolated
from 1 - day - old F2 female mice produced by interbreeding C57BL6 × CBA F1 mice.
Their three - dimensional
cell - culture system, adapted for high - throughput screening, has enabled them to identify small molecules that can inhibit adhesion and invasion, preventing
ovarian cancers
from spreading to nearby tissues.
October 30, 2011 Fat
cells in abdomen fuel spread of
ovarian cancer A large pad of fat
cells that extends
from the stomach and covers the intestines provides nutrients that promote the spread and growth of
ovarian cancer, reports a research team based at the University of Chicago in the journal Nature Medicine, published online October 30th, 2011.
A large pad of fat
cells that extends
from the stomach and covers the intestines provides nutrients that promote the spread and growth of
ovarian cancer, reports a research team based at the University of Chicago in the journal Nature Medicine, published online October 30th, 2011.
The approach developed by the MGH team starts with the engineered protein, which in this case fuses an antibody fragment targeting a protein called mesothelin — expressed on the surface of such tumors as mesothelioma,
ovarian cancer and pancreatic cancer — to a protein
from the tuberculosis bacteria that stimulates the activity of dendritic and other immune
cells.
Using state - of - the - art proteomics and associated computational methods, the Speicher laboratory is investigating protein changes associated with
ovarian cancer, melanoma, cardiac injury resulting
from breast cancer therapies, ectopic pregnancy, red
cell diseases, and other clinical disorders.
February 10, 2015 New screening tool could speed development of
ovarian cancer drugs University of Chicago Medicine researchers have built a model system that uses multiple
cell types
from patients to rapidly test compounds that could block the early steps in
ovarian cancer metastasis.
University of Chicago Medicine researchers have built a model system that uses multiple
cell types
from patients to rapidly test compounds that could block the early steps in
ovarian cancer metastasis.
Next,
ovarian cancer
cells, expressing a fluorescent marker to distinguish them
from the other
cells, were added.
According to the American Cancer Society, ginger can combat
ovarian cancer by blocking the cancer
cells from growing, preventing it
from spreading and causing more harm to the body.
For the study, Levine and his colleagues performed genetic analyses of
ovarian cancer
cells from 96 patients.